retatrutide clinical trials efficacy approval: FDA status, trial results, and when it could be available Retatrutide, a new weight loss

2,275 participants were treated with GLP-1 medicines such as liraglutide, dulaglutide, exenatide, semaglutide, and tirzepatide

A potential mechanism is via GLP-1, which alters gastrointestinal transit, gastric accommodation (45, 46, 63), and has direct effects on hypothalamic nuclei outside of the bloodbrain barrier (64)

Obesity and Erectile Dysfunction: From Bench to Clinical Implication

These C-cells produce calcitonin, a hormone involved in calcium regulation

And when they stop, the weight comes back a 2025 meta-analysis in The Lancet found that patients who discontinued semaglutide or tirzepatide regained an average of nearly 10 kilograms

Possible positive effects that some patients report include: Improved mood and reduced anxiety symptoms potentially linked to successful weight loss and better metabolic control [6] Enhanced self-esteem and body image as weight reduction progresses Reduced food-related anxiety and preoccupation with eating, though evidence for effects on binge eating is limited and observational Better sleep quality in some patients, though this is anecdotal and not well-established in clinical trials These improvements, when they occur, are generally considered secondary to metabolic benefits rather than direct anxiolytic effects